E-LIB Suche - Ergebnisse für: Cherny, Ruslan I.

1

The Mushiston Sn deposit in Tajik Tien Shan as the type loc..:

Konopelko, Dmitry L. ; Cherny, Ruslan I. ; Petrov, Sergei V....
Journal of Geochemical Exploration. 239 (2022) - p. 107017 , 2022

Link: https://doi.org/10.1016/..

2

Ethical considerations in the relief of cancer pain:

Cherny, Nathan I. ; Ziff-Werman, Batsheva
Supportive Care in Cancer. 31 (2023) 7 - p. , 2023

Link: https://doi.org/10.1007/..

3

Off-label despite high-level evidence: a clinical practice ..:

Zarkavelis, G. ; Amylidi, A.L. ; Verbaanderd, C....
ESMO Open. 8 (2023) 1 - p. 100604 , 2023

Link: https://doi.org/10.1016/..

4

Methodological and reporting standards for quality-of-life ..:

Oosting, S.F. ; Barriuso, J. ; Bottomley, A....
Annals of Oncology. 34 (2023) 4 - p. 431-439 , 2023

Link: https://doi.org/10.1016/..

5

PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMAT..:

Kiesewetter, Barbara ; Dafni, Urania ; de Vries, Elisabeth G E...
HemaSphere. 7 (2023) S3 - p. e02308e3 , 2023

Link: https://doi.org/10.1097/..

6

Essential cancer medicines: adding feasibility to the magni..:

Roitberg, F. ; Amaral, T. ; Cherny, N.I....
ESMO Open. 8 (2023) 5 - p. 101617 , 2023

Link: https://doi.org/10.1016/..

7

Evaluation of the ESMO-Magnitude of Clinical Benefit Scale ..:

Sapir, E. ; Cherny, N.I. ; Ennis, R.D....
ESMO Open. 8 (2023) 3 - p. 101206 , 2023

Link: https://doi.org/10.1016/..

8

Does the European Society of Medical Oncology-Magnitude of ..:

Sapir, E. ; Cherny, N.I. ; Ennis, R.D....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. e335 , 2022

Link: https://doi.org/10.1016/..

9

An appraisal of FDA approvals for adult solid tumours in 20..:

Cherny, Nathan I.
Nature Reviews Clinical Oncology. 19 (2022) 7 - p. 486-492 , 2022

Link: https://doi.org/10.1038/..

10

Implementation of the ESMO-Magnitude of Clinical Benefit Sc..:

Wolf, I. ; Waissengrin, B. ; Zer, A....
ESMO Open. 7 (2022) 1 - p. 100379 , 2022

Link: https://doi.org/10.1016/..

11

"The first ones now, will later be last": understanding the..:

Cherny, N.I. ; Dafni, U. ; Pentheroudakis, G....
ESMO Open. 7 (2022) 2 - p. 100413 , 2022

Link: https://doi.org/10.1016/..

12

Prioritising systemic cancer therapies applying ESMO's tool..:

Latino, N.J. ; Galotti, M. ; Cherny, N.I....
ESMO Open. 7 (2022) 1 - p. 100362 , 2022

Link: https://doi.org/10.1016/..

13

Роль сукцинатоксидазного окисления в интенсивной терапии тя..:

Cherny, V.I. ; Andronova, I.A. ; Gorodnik, G.A...
EMERGENCY MEDICINE. , 2021

Link: https://doi.org/10.22141..

14

Biases in study design, implementation, and data analysis t..:

Gyawali, B. ; de Vries, E.G.E. ; Dafni, U....
ESMO Open. 6 (2021) 3 - p. 100117 , 2021

Link: https://doi.org/10.1016/..

15

The global imperative to make cancer medications affordable:

Cherny, Nathan I ; de Vries, Elisabeth G E
The Lancet Oncology. 21 (2020) 5 - p. 609-610 , 2020

Link: https://doi.org/10.1016/..